Enalare Therapeutics, INC.
Biopharmaceutical company
Based in NJ
AI Overview
With $10K in lobbying spend across 8 quarterly filings, Enalare Therapeutics, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $0 |
| 2022 | $10K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Enalare Therapeutics, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Defense
Discussion of DoD funding of drug therapy research
Meetings with officials regarding the relevance of respiratory stimulants to the DOD.
National Defense Authorization Act for FY23, provisions relating to the relevance of respiratory stimulants to the DOD.
HR 7900 National Defene Authorization Act for FY23, proviion relating to respiratory stimulants.
HR 7900 National Defense Authorization Act for FY23, provision relating to respiratory stimulants.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.